Literature DB >> 17038471

Can studies of tolerance ever lead to therapy?

H von Boehmer1.   

Abstract

Studies in murine models have suggested that regulatory T (Treg) cells can be generated by any antigen and such antigen specific Treg cells not only prevent but also reverse unwanted immunity. Another key finding of these experimental studies is that Treg cells could possibly be used therapeutically to ameliorate disease because of their ability to interfere with the execution of effector programmes of fully differentiated T effector cells. However, more work is needed before these findings can be safely translated into better targeted therapy and prevention of unwanted immune responses in clinical settings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17038471      PMCID: PMC1798370          DOI: 10.1136/ard.2006.058396

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  22 in total

1.  Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen.

Authors:  K M Thorstenson; A Khoruts
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

2.  In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro.

Authors:  Ludger Klein; Khashayarsha Khazaie; Harald von Boehmer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-11       Impact factor: 11.205

3.  Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors.

Authors:  Chyi-Song Hsieh; Yuqiong Liang; Aaron J Tyznik; Steven G Self; Denny Liggitt; Alexander Y Rudensky
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

4.  Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells.

Authors:  Karsten Mahnke; Yingjie Qian; Jürgen Knop; Alexander H Enk
Journal:  Blood       Date:  2003-01-23       Impact factor: 22.113

5.  Origin of regulatory T cells with known specificity for antigen.

Authors:  Irina Apostolou; Adelaida Sarukhan; Ludger Klein; Harald von Boehmer
Journal:  Nat Immunol       Date:  2002-07-01       Impact factor: 25.606

6.  Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells.

Authors:  Jochen Huehn; Kerstin Siegmund; Joachim C U Lehmann; Christiane Siewert; Uta Haubold; Markus Feuerer; Gudrun F Debes; Joerg Lauber; Oliver Frey; Grzegorz K Przybylski; Uwe Niesner; Maurus de la Rosa; Christian A Schmidt; Rolf Bräuer; Jan Buer; Alexander Scheffold; Alf Hamann
Journal:  J Exp Med       Date:  2004-02-02       Impact factor: 14.307

7.  In vivo instruction of suppressor commitment in naive T cells.

Authors:  Irina Apostolou; Harald von Boehmer
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307

8.  CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

Authors:  Kristin V Tarbell; Sayuri Yamazaki; Kara Olson; Priscilla Toy; Ralph M Steinman
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

9.  In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.

Authors:  Qizhi Tang; Kammi J Henriksen; Mingying Bi; Erik B Finger; Greg Szot; Jianqin Ye; Emma L Masteller; Hugh McDevitt; Mark Bonyhadi; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

10.  Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo.

Authors:  Lucy S K Walker; Anna Chodos; Mark Eggena; Hans Dooms; Abul K Abbas
Journal:  J Exp Med       Date:  2003-07-21       Impact factor: 14.307

View more
  2 in total

1.  Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis.

Authors:  Frank Behrens; Andrea Himsel; Stefan Rehart; Joanna Stanczyk; Björn Beutel; Stefanie Y Zimmermann; Ulrike Koehl; Burkhard Möller; Steffen Gay; Joachim P Kaltwasser; Josef M Pfeilschifter; Heinfried H Radeke
Journal:  Ann Rheum Dis       Date:  2007-03-28       Impact factor: 19.103

2.  Specific immunosuppression with inducible Foxp3-transduced polyclonal T cells.

Authors:  Kristian G Andersen; Tracey Butcher; Alexander G Betz
Journal:  PLoS Biol       Date:  2008-11-11       Impact factor: 8.029

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.